Type 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria
- Carla J. Greenbaum,
- David Cuthbertson,
- Jeffrey P. Krischer and
- the Diabetes Prevention Trial of Type 1 Diabetes Study Group
- From the Department of Veterans Affairs (C.J.G.), Puget Sound Health Care System and the Department of Medicine (C.J.G.), University of Washington, Seattle, Washington; and the H. Lee Moffitt Cancer Center and Research Institute (D.C., J.P.K.), University of South Florida, Tampa, Florida.
- Address correspondence and reprint requests to Carla Greenbaum MD, Diabetes Clinical Research Unit, Clinical Research Center, Virginia Mason Research Center, 1201 9th Ave., Seattle, WA 98101. E-mail: cjgreen{at}vmresearch.org .
Abstract
The clinical presentation of type 1 diabetes usually involves symptoms such as polyuria and polydipsia. However, investigators in the Diabetes Prevention Trial of Type 1 Diabetes (DPT-1) have detected a group of subjects with type 1 diabetes who have a different phenotype. These subjects are asymptomatic, have normal (<6.1 mmol/l) (group A) or impaired (6.1- <7.0 mmol/l) (group B) fasting glucose, but have 2-h glucose values >11.1 mmol/l on their oral glucose tolerance tests (OGTT). Of the 585 OGTTs performed on islet cell antibody (ICA)-positive relatives with insulin autoantibodies (IAA) or low first-phase insulin response (FPIR), normal glucose tolerance (NGT) was found in 427 subjects; impaired glucose tolerance (IGT) was found in 87 subjects, and diabetes was found by 2-h OGTT criteria alone in 61 subjects. Despite marked differences in 2-h glucose values (NGT 5.8 ± 1.1 mmol/l, IGT 8.9 ± 0.9 mmol/l, and group A 13.5 ± 2.5 mmol/l), there were no significant differences in fasting glucose values among NGT (4.8 ± 0.5 mmol/l), IGT (5.03 ± 0.5 mmol/l), and group A (4.99 ± 0.7 mmol/l) categories. Mean FPIR was higher in subjects with NGT compared with subjects with IGT and subjects diagnosed by 2-h OGTT criteria alone. However, the correlation between FPIR and 2-h glucose value was low (r2 = 0.14). Multivariate analysis demonstrated that additional independent variables provide smaller contributions to the 2-h glucose value. In conclusion, there are asymptomatic type 1 diabetic subjects whose diabetes was diagnosed by the 2-h criteria on OGTT alone. Despite the importance of β-cell dysfunction in the pathogenesis of type 1 diabetes, factors other than impaired FPIR must also contribute to postprandial glucose tolerance in these subjects.
Footnotes
-
AUC, area under the curve; DPT-1, Diabetes Prevention Trial of Type 1 Diabletes; FPIR, first-phase insulin response; HOMA-β, homeostasis model assessment of β-cell function; HOMA-IR, homeostasis model assessment of insulin resistance; IAA, insulin autoantibody; ICA, islet cell antibody; IDS, Immunology of Diabetes Society; IGT, impaired glucose tolerance; IVGTT, intravenous glucose tolerance test; JDF U, Juvenile Diabetes Foundation units; NDDG, National Diabetes Data Group; NGT, normal glucose tolerance; NIH, National Institutes of Health; OGTT, oral glucose tolerance test.
-
- Accepted October 16, 2000.
- Received August 18, 1999.
- by the American Diabetes Association, Inc.














